Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/1998
05/22/1998CA2271116A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998CA2270985A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/22/1998CA2270634A1 Methods and compositions for stimulating neurite growth
05/22/1998CA2270629A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
05/22/1998CA2269035A1 Indene inhibitors of cox-2
05/22/1998CA2268018A1 Peptides capable of inhibiting the endocytosis of the app and corresponding nucleotide sequences
05/20/1998EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein
05/20/1998EP0843014A2 Tryptophanyl tRNA synthetase
05/20/1998EP0843011A2 RsbU-1 derived from Staphylococcus
05/20/1998EP0842934A1 5-HT1F agonists
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842297A1 Methods of predicting the outcome of infection
05/20/1998EP0842268A2 Methods and compositions for identifying morphogen analogs
05/20/1998EP0842195A1 Peptide inhibitors of fibronectine
05/20/1998EP0842189A1 Early onset alzheimer's disease gene and gene products
05/20/1998EP0842178A1 Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
05/20/1998EP0842176A1 Heterocyclic compounds, their preparation and use
05/20/1998EP0842173A1 4-[3-(trans-3-dimethylaminocyclobutyl)-1h-indol-5-ylmethyl]-4(s)oxazolidin-2-one monobenzoate and sulphate salt
05/20/1998EP0842172A1 Novel substituted azacyclic or azabicyclic compounds
05/20/1998EP0842170A1 Diphenylmethylene piperidine derivatives
05/20/1998EP0842152A1 N-(4-substituted-benzyl)-2-aminolactam derivatives
05/20/1998EP0842143A1 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
05/20/1998EP0841950A1 Neuronal progenitor cells and uses thereof
05/20/1998EP0841937A1 Use of betaglycan to reduce scarring
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841928A1 Sustained-release formulation of d-threo-methylphenidate
05/20/1998EP0841923A1 1h-4(5)-substituted imidazole derivatives
05/20/1998EP0841922A1 1h-4(5)-substituted imidazole derivatives
05/20/1998EP0841918A1 Thrombin inhibitors
05/20/1998EP0841907A1 Use of agonists or antagonists of p 2? purinoceptors for the prevention of glutamate-evoked cytotoxicity
05/20/1998EP0643690B1 Desferrioxamine-b salts and their use as orally effective iron chelators
05/20/1998EP0608336B1 Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment
05/20/1998CN1182430A Carbohydrate conjugated bio-active compounds
05/20/1998CN1182427A Benzimidazole compounds and their use as modulators of the GABAA receptor complex
05/20/1998CN1182426A Benzimidazole compounds and their use as modulators of the GABAA receptor complex
05/20/1998CN1182425A Benzimidazole compounds and their use as modulators of the GABAA receptor complex
05/20/1998CN1182422A 3 -phenyl -1, 4 -dialkyl -1, 2, 4 -triazolium salts and their use as antidepressants
05/20/1998CN1182417A Indole derivatives
05/20/1998CN1182416A Benzamides for neurodegenerative disorder treatment
05/20/1998CN1182369A Pharmaceutical compositions for controlled release of soluble receptors
05/20/1998CN1182365A Pharmaceutical compostion for transdermic delivery
05/20/1998CN1182358A Triacetin as transdermal penetration enhancer
05/20/1998CN1182083A New heterocyclic aminomethyl compounds, process for preparing them and pharmaceutical compositions containing them
05/19/1998US5753708 Anesthetics, treatment of sleep disorders
05/19/1998US5753693 Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder
05/19/1998US5753690 Treating psychoses
05/19/1998US5753688 Antiinflammatory
05/19/1998US5753682 Imidazole lipoxygenase inhibitors
05/19/1998US5753679 Scizophrenia
05/19/1998US5753678 Heterocyclic compounds
05/19/1998US5753665 Therapeutic agents
05/19/1998US5753663 5ht2c antagonist, useful for treating anxiety, pain, obsessive compulsive disorder, alcoholism, depression, migraine, sleep disorder, anorexia nervosa and priapism
05/19/1998US5753662 Treating dopaminergic system disorders
05/19/1998US5753661 Fused benzo compounds containing a nitrogen heterocycle for the treatment of central nervous system disorders
05/19/1998US5753657 Imidazo 1,2-A! pyrazine-4-one, preparation thereof and drugs containing same
05/19/1998US5753646 Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them
05/19/1998US5753643 Heterocyclic compounds
05/19/1998US5753641 Method of treatment for benign prostatic hyperplasia
05/19/1998US5753624 Materials and methods for treatment of plaquing disease
05/19/1998US5753505 Genetic expressing a marker, cell differentiation for treating nervous system disorder, alzheimer's disease
05/19/1998US5753491 Use of neuro-derived fetal cell lines for transplantation therapy
05/19/1998CA2096611C 4-benzylpiperidine derivatives and process for their production
05/14/1998WO1998020119A1 Fatty-acid amide hydrolase
05/14/1998WO1998020040A1 Novel histamine h2 receptor
05/14/1998WO1998020022A1 Soluble proteins
05/14/1998WO1998020010A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998019999A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
05/14/1998WO1998019706A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998WO1998019690A1 Method for treating alzheimer's disease
05/14/1998WO1998019687A1 Natural teas for taking off the effects of drink and process for the production thereof
05/14/1998WO1998019676A1 Method for treatment of glutamate related disorders
05/14/1998WO1998019513A2 Method for the preparation of citalopram
05/14/1998WO1998019512A2 Method for the preparation of citalopram
05/14/1998WO1998019511A2 Method for the preparation of citalopram
05/14/1998WO1998007859A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998005776A3 Secreted proteins and polynucleotides encoding them
05/14/1998WO1998005291A3 Method for treating mental retardation
05/14/1998CA2593733A1 A method for treating tension-type headache
05/14/1998CA2270922A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998CA2270909A1 Novel histamine h2 receptor
05/14/1998CA2270780A1 Method for treating alzheimer's disease
05/14/1998CA2270293A1 Fatty-acid amide hydrolase
05/14/1998CA2269858A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
05/14/1998CA2269838A1 Method for treatment of glutamate related disorders
05/14/1998CA2268354A1 Soluble proteins
05/14/1998CA2268126A1 Quinolines and their therapeutic use
05/13/1998EP0841330A1 Aminomethyl heterocyclic derivatives, process of their preparation and pharmaceutical compositions containing them
05/13/1998EP0840801A2 Methods and compositions for identifying morphogen analogs
05/13/1998EP0840788A1 Novel serpin derived from human hypothalamus
05/13/1998EP0840735A1 Resolution of 1-azabicyclo 2.2.2]octan-3-amine, 2-(diphenylmethyl)-n- 2-methoxy-5-(1-methylethyl)phenyl]methyl]
05/13/1998EP0840733A1 A triazolylmethyl-indole ethylamine bisulfate salt
05/13/1998EP0840732A1 Substituted benzolactam compounds as substance p antagonists
05/13/1998EP0840731A1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists
05/13/1998EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease
05/13/1998EP0840609A1 Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
05/13/1998EP0840605A1 Compounds useful in the treatment of neurofibromatosis
05/13/1998EP0840603A1 Pharmaceutical composition of l-dopa ethyl ester
05/13/1998EP0840601A1 Non-allosteric gaba-a agonists for treating sleep disorders
1 ... 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 ... 1833